Hematopoietic stem cell transplantation in severe congenital neutropenia: Experience of the French SCN register

Bone Marrow Transplantation

Volumn 35, Issue 1, 2005, Pages 45-50

  Ferry, C ^a   Ouachee M ^b   Leblanc, T ^a   Michel, G ^c   Notz Carrere A ^d   Tabrizi, R ^d   Flood, T ^e   Lutz, P ^f   Fischer, A ^b   Gluckman, E ^a   Donadieu, J ^g  

^a SAINT LOUIS HOSPITAL   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c TIMONE HOSPITAL   (France)

^d HAUT LÉVÊQUE HOSPITAL   (France)

^e NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^f HÔPITAL DE HAUTEPIERRE   (France)

^g ARMAND TROUSSEAU HOSPITAL   (France)

Author keywords

Hematopoietic stem cell transplantation; Myelodysplasia; Severe chronic neutropenia

Indexed keywords

AMSACRINE; BUSULFAN; CD20 ANTIBODY; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; ETOPOSIDE; FLUDARABINE; FOSCARNET SODIUM; GANCICLOVIR; GRANULOCYTE COLONY STIMULATING FACTOR; MEPREDNISONE; METHOTREXATE; MITOXANTRONE; THIOTEPA; THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BONE MARROW DEPRESSION; CAUSE OF DEATH; CHILD; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CYTOMEGALOVIRUS INFECTION; DISEASE COURSE; DISEASE SEVERITY; DRUG MEGADOSE; EPSTEIN BARR VIRUS; FEASIBILITY STUDY; FEMALE; FOLLOW UP; FRANCE; GRAFT REJECTION; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HIGH RISK PATIENT; HLA MATCHING; HUMAN; LEUKEMIA; LYMPHOPROLIFERATIVE DISEASE; MALE; MALIGNANT TRANSFORMATION; MYELODYSPLASTIC SYNDROME; NEUTROPENIA; PRIORITY JOURNAL; REGISTER; REMISSION; TREATMENT FAILURE; TREATMENT INDICATION; VIRUS INFECTION; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; BONE MARROW CELLS; CELL TRANSFORMATION, NEOPLASTIC; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; FRANCE; GRAFT VS HOST DISEASE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; LEUKEMIA; LYMPHOPROLIFERATIVE DISORDERS; MALE; MODELS, STATISTICAL; MYELODYSPLASTIC SYNDROMES; NEUTROPENIA; RECURRENCE; REGISTRIES; TIME FACTORS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS;

EID: 19944427804     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704718     Document Type: Article

References (22)

1. Kostmann R. Infantile genetic agranulocytosis. Acta Paediatr Scand 1956; 45 (Suppl 105): 1-78.
2. Kostmann R. Infantile genetic agranulocytosis. Acta Paediatr Scand 1975; 64: 362-368.
3. Ancliff PJ, Gale RE, Liesner R et al. Mutations in the ELA2 gene encoding neutrophil elastase are present in most patients with sporadic severe congenital neutropenia but only in some patients with the familial form of the disease. Blood 2001; 98: 2645-2650.
4. Bellanne-Chantelot C, Clauin S, Leblanc T et al. Mutations in the ELA2 gene correlate with more severe expression of neutropenia: a study of 81 patients from the French Neutropenia Register. Blood 2004; 103: 4119-4125.
5. Dale DC, Person RE, Bolyard AA et al. Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia. Blood 2000; 96: 2317-2322.
6. Person RE, Li FQ, Duan Z et al. Mutations in proto-oncogene GFI1 cause human neutropenia and target ELA2. Nat Genet 2003; 34: 308-312.
7. Dale DC, Cottle TE, Fier CJ et al. Severe chronic neutropenia: treatment and follow-up of patients in the Severe Chronic Neutropenia International Registry. Am J Hematol 2003; 72: 82-93.
8. Bonilla MA, Gillio AP, Ruggeiro M et al. Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis. N Engl J Med 1989; 320 1574-1580.
9. Dallorso S, Manzitti C, Dodero P et al. Uneventful outcome of unrelated hematopoietic stem cell transplantation in a patient with leukemic transformation of Kostmann syndrome and long-lasting invasive pulmonary mycosis. Eur J Haematol 2003; 70: 322-325.
10. Rappeport JM, Parkman R, Newburger P et al. Correction of infantile agranulocytosis (Kostmann's syndrome) by allogeneic bone marrow transplantation. Am J Med 1980; 68: 605-609.
11. Toyoda H, Azuma E, Hori H et al. Successful unrelated BMT in a patient with Kostmann syndrome complicated by pre-transplant pulmonary 'bacterial' abscesses. Bone Marrow Transplant 2001; 28 413-415.
12. Zeidler C, Welte K, Barak Y et al. Stem cell transplantation in patients with severe congenital neutropenia without evidence of leukemic transformation. Blood 2000; 95: 1195-1198.
13. Donadieu J, Leblanc T, Bader-Meunier B et al. Analysis of risk factors for myelodysplasia/leukemia and infectious death among patients with congenital neutropenia. Experience of the French Severe Chronic Neutropenia Study Group. Hematol J 2004; in press.
14. Michel G, Landman-Parker J, Auclerc MF et al. Use of recombinant human granulocyte colony-stimulating factor to increase chemotherapy dose-intensity: a randomized trial in very high-risk childhood acute lymphoblastic leukemia. J Clin Oncol 2000; 18 1517-1524.
15. Perel Y, Auvrignon A, Leblanc T et al. Maintenance therapy in childhood acute myeloid leukemia. Ann Hematol 2004; 83 (Suppl 1): S116-S119.
16. Stoll C, Alembik Y, Lutz P. A syndrome of facial dysmorphia, birth defects, myelodysplasia and immunodeficiency in three sibs of consanguineous parents. Genet Counsel 1994; 5: 161-165.
17. Carlsson G, Fasth A. Infantile genetic agranulocytosis, morbus Kostmann: presentation of six cases from the original 'Kostmann family' and a review. Acta Paediatr 2001; 90: 757-764.
18. Amrolia P, Gaspar HB, Hassan A et al. Nonmyeloablative stem cell transplantation for congenital immunodeficiencies. Blood 2000; 96: 1239-1246.
19. Freedman MH, Bonilla MA, Fier C et al. Myelodysplasia syndrome and acute myeloid leukemia in patients with congenital neutropenia receiving G-CSF therapy. Blood 2000; 96: 429-436.
20. Anderson JE, Gooley TA, Schoch G et al. Stem cell transplantation for secondary acute myeloid leukemia: evaluation of transplantation as initial therapy or following induction chemotherapy. Blood 1997; 89: 2578-2585.
21. Cassinat B, Bellanne-Chantelot C, Notz-Carrére A et al. Screening for G-CSF receptor mutations in patients with secondary myeloid or lymphoid transformation of severe congenital neutropenia. Leukemia 2004; 18: 1553-1555.
22. Germeshausen M, Ballmaier M, Schulze H et al. Granulocyte colony-stimulating factor receptor mutations in a patient with acute lymphoblastic leukemia secondary to severe congenital neutropenia. Blood 2001; 97: 829-830.